That article about evergreening was depressing! apparently, in the case of top 10 drugs, instead of receiving their allocated 20 years of competition-free profits, they managed to extend their patent life to 38years!
Then I read that these Big Pharma like to intimidate the generic producers with all sorts of law suits!
My father likes to annoy me by repeatedly telling me that the world operates by practising the Golden Rule: “Them that has the gold get to make the rules!”
The system is what it is…there is nothing little ol’ me can do about it, nor can Race, and for the matter, nor can Amgen…but that doesn’t change the fact, in my head,that the the Big Pharma collective has permitted these cunning “evergreening” manoeuvres, just because they can!
It's a pendulum thing: eventually these powerful entities will so badly abuse their power that corrective forces will step in…it happened in the 1930s (???) with the US government having to bring in anti-trust laws.
- Forums
- ASX - By Stock
- RAC
- Ann: Expanded Heart Protection Discovery for Zantrene
Ann: Expanded Heart Protection Discovery for Zantrene, page-172
-
- There are more pages in this discussion • 215 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.94 |
Change
0.000(0.00%) |
Mkt cap ! $330.4M |
Open | High | Low | Value | Volume |
$1.95 | $1.95 | $1.84 | $647.3K | 344.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | $1.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.94 | 5654 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | 1.870 |
4 | 46789 | 1.840 |
2 | 6500 | 1.830 |
2 | 649 | 1.820 |
1 | 829 | 1.805 |
Price($) | Vol. | No. |
---|---|---|
1.940 | 5654 | 2 |
1.950 | 7570 | 1 |
1.960 | 1350 | 1 |
1.990 | 4701 | 2 |
1.995 | 10037 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online